Executives from Cencora, Inc., CVS Health, Walgreens Boots Alliance, and Eli Lilly and Company headline fireside chats during by-invitation March event. MALVERN, Pa., (September 10, 2024) — An agenda that features future trends, supply chain resilience, and policy and regulatory […] more >
Nation’s top drug channel company leaders to join fireside chats on key issues, pressing challenges facing the U.S. prescription drug market and healthcare system. MALVERN PA, (June 24, 2024) — Drug Channels Institute, an HMP Global Company, will host four […] more >
HMP Global’s Drug Channels Institute plans inaugural Leadership Forum for pharmaceutical industry executives Dynamic, interactive program will focus on industry trends and challenges, tailored for executives throughout the drug distribution ecosystem. MALVERN PA, (April 8, 2024) — Drug Channels Institute, […] more >
Report: U.S. prescription revenues reach $621 billion, remain highly consolidated with large PBMs. Malvern PA (March 19, 2024) — Drug Channels Institute (DCI), an HMP Global Company, today released its exclusive, in-depth analysis of U.S. pharmacies and pharmacy benefit managers […] more >
PHILADELPHIA (PRWeb) October 10, 2023— Today Drug Channels Institute (DCI) released its exclusive analysis of U.S. prescription drug distribution channels. DCI’s new 2023–24 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors delves into the business operations and industry environment of […] more >